Home Financial Markets Penny Stocks Why Did ONPH Stock Soar 93% On Monday?

Why Did ONPH Stock Soar 93% On Monday?

At the previous close, the Oncology Pharma Inc. (OTCPINK: ONPH) share price rose noticeably, rising 93.40% to $37.00. Compared to the gain of 37.29% in the previous month, Oncology Pharma stock gained 45.38% over the last week. Recent news of an agreement pertaining to mRNA intellectual property (IP) triggered a surge of ONPH stock.

What is that IP deal all about?

Currently, Oncology Pharma is partnering with world-class advisory boards for oncology research and development. With these characteristics, ONPH is able to maintain a leading position when it comes to cancer research, healthcare, and biotechnology.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Oncology Pharma last week agreed to develop a therapeutic using mRNA for pancreatic cancer under a license agreement with Regen BioPharma Inc.

  • ONPH plans to utilize this licensing agreement to expand its niche biotechnology intellectual property portfolio.
  • In a statement, ONPH said that it intended to increase its presence in the cancer therapy market.
  • The ONPH commitment to developing quality therapies to make patients lives better is exemplified by this effort.
  • A spokesperson for ONPH said at the time the ONPH views this as a significant achievement in brand development and is evidence of it achieving its annual marketing goals.

Earlier updates:

Earlier in the previous month, Oncology Pharma (ONPH) unveiled its plans to develop and grow its business model and intellectual property. ONPH’s focus points include expanding its cancer therapies through the acquisition of licenses, formation of synergistic partnerships, and development of other niche therapies.

Additionally, ONPH’s strategic planning includes the goal of establishing financial partnerships that will enable licensed therapeutic agents to be developed. And the ONPH is heading in the right direction, as evidenced by the current developments.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial

Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share...

Prophase Labs Inc. (PRPH) stock surged during pre-market trading session. Let’s figure out why?

Prophase Labs Inc. (NASDAQ: PRPH) stock soared by 5.87% at last close as well as the PRPH stock price has been observed rising by...

Why Surgalign Holdings, Inc. (SRGA) stock is gloomy today?

Surgalign Holdings, Inc. (SRGA) stock announced the $50 million registered direct offering priced at the market under Nasdaq rules today on June 10, 2021,...

Exela Technologies Inc. (XELA) stock soars during pre-market. Here’s what you should know?

Exela Technologies Inc. (NASDAQ: XELA) stock gained by 8.28% at last close while the XELA stock price rises in the pre-market as well, by...

Atossa Therapeutics, Inc. (ATOS) stock gains during pre-market trading. Here’s to know why?

Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock declined by 27.51% at the last close while the ATOS stock price rises further by 9.09% in the...

Magnachip Semiconductor Corporation (MX) stock is Popping High today: Why is it so?

Shares of the Magnachip Semiconductor Corporation (MX) stock were popping high after the announcement of its receival of unsolicited buyout bid from Cornucopia Investment...

Why is Autolus Therapeutics plc (AUTL) stock rising today?

Shares of  Autolus Therapeutics plc (AUTL) stock were rising today on June 11, 2021, following the release of the presentation data related to obe-cel...

Mustang Bio, Inc. (MBIO) stock is climbing today: Here is to know why.

Mustang Bio, Inc. (MBIO) stock announced the updated interim data from Phase 1/2 clinical trial of its MB-106 CD20-targeted, autologous CAR T today on...

Related News

What Caused The Sino United Worldwide (SUIC) Stock To Drop 50%?

In the last session, the price of Sino United Worldwide Consolidated Ltd (OTCPink: SUIC) spiraled -50.82% to $5.4000. During the session, Sino United's stock...

On What Basis Did HIRU Stock Rise 43%?

Hiru Corp stock blasted into the green at the previous close, rising 43.00% to $0.0143. Volume was 65.87 million against 30-day Average Volume...

Is There Any Reason As To Why The BIGG Digital (BBKCF) Stock Expanded By 30%?

A share of BIGG Digital Assets Inc (OTCQX: BBKCF) rose 30.78 at yesterday's close, to $1.4670. There was an increase in volume of BIGG...

Why Has The Ascot (AOTVF) Stock Price Gained 20%?

The stock of Ascot Resources Ltd (OTCQX: AOTVF) gained significantly as it increased by 20.50% to $0.8858 at last close. The Ascot stock price...

How Does The KinerjaPay (KPAY) Stock Price Increase By 454%?

The payment gateway and eCommerce company KierjaPay Corporation (OTCPink: KPAY) closed Tuesday's trading session at $0.0122, up 454.55%, and has been trading in a...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam